Find support groups, events and resources near you

ZERO Summit 2021 banner

PARP Inhibitors Treatment Update

Graphic about PARP Inhibitors

After receiving approval for breast and ovarian cancer, PARP inhibitors were finally sanctioned by the FDA for prostate cancer last year. Watch Dr. Alan Bryce from the Mayo Clinic in this video to understand which patients could benefit from these treatments and to receive the latest updates from relevant clinical trials.

This session was part of our VIRTUAL ZERO Prostate Cancer Summit, a free online event that took place from February 28 to March 4, 2021.


Watch

Contributors

Alan Bryce Headshot
Alan Bryce MD, Medical Director of the Genomic Oncology Clinic

Dr. Bryce studies cancer genetics and novel therapeutics with a focus on personalized medicine. His clinical practice centers on genitourinary malignancies (prostate, kidney, bladder, and testicular cancers) and melanoma.

Share